Chadi Aludaat1, Alexandre Canville2, Quentin Landolff2, Matthieu Godin2, Fabrice Bauer3, Fabien Doguet3. 1. Department of Cardiac Surgery, Heart Team Unit, Rouen University Hospital, Hôpital Charles Nicolle, F76000, Rouen, France. chadi.aludaat@chu-rouen.fr. 2. Department of Cardiology, Clinique St. Hilaire, Heart Team Unit, F76000, Rouen, France. 3. Department of Cardiac Surgery, Heart Team Unit, Rouen University Hospital, Hôpital Charles Nicolle, F76000, Rouen, France.
Abstract
BACKGROUND: The ACURATE neo™ transcatheter heart valve (Boston Scientific, Marlborough, Massachusetts) is predominantly implanted via femoral access. Transcarotid use of this prothesis has never been reported. CASE PRESENTATION: We present the case of an 89-year-old woman referred to us for a transcatheter aortic valve replacement (TAVR). After apparatus imaging of the aortic annulus and the peripheral vascular pathway, the heart team was confronted with a triple challenge: (i) The preferable choice of a self-expanding valve because of a small aortic annulus in an obese woman. (ii) Gaining favorable access to the coronary ostia, considering multiple recent coronary stenting. (iii) Utilizing an alternative arterial access because of iliac and femoral severely calcified stenosis. Implanting the ACURATE neo™ transcatheter heart valve (THV) via carotidal access allowed us to overcome these challenges. The procedure was performed successfully without any short-term complications. CONCLUSION: We report the first case of implantation of an ACURATE neo™ transcatheter heart valve (Boston Scientific, Marlborough, Massachusetts) via the right common carotid artery.
BACKGROUND: The ACURATE neo™ transcatheter heart valve (Boston Scientific, Marlborough, Massachusetts) is predominantly implanted via femoral access. Transcarotid use of this prothesis has never been reported. CASE PRESENTATION: We present the case of an 89-year-old woman referred to us for a transcatheter aortic valve replacement (TAVR). After apparatus imaging of the aortic annulus and the peripheral vascular pathway, the heart team was confronted with a triple challenge: (i) The preferable choice of a self-expanding valve because of a small aortic annulus in an obesewoman. (ii) Gaining favorable access to the coronary ostia, considering multiple recent coronary stenting. (iii) Utilizing an alternative arterial access because of iliac and femoral severely calcified stenosis. Implanting the ACURATE neo™ transcatheter heart valve (THV) via carotidal access allowed us to overcome these challenges. The procedure was performed successfully without any short-term complications. CONCLUSION: We report the first case of implantation of an ACURATE neo™ transcatheter heart valve (Boston Scientific, Marlborough, Massachusetts) via the right common carotid artery.
Entities:
Keywords:
Carotid artery access; Case report; TAVR
Authors: Won-Keun Kim; Helge Möllmann; Christoph Liebetrau; Matthias Renker; Andreas Rolf; Philippe Simon; Arnaud Van Linden; Mani Arsalan; Mirko Doss; Christian W Hamm; Thomas Walther Journal: JACC Cardiovasc Interv Date: 2018-05-23 Impact factor: 11.195